Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001062993-10-000014
Filing Date
2010-01-05
Accepted
2010-01-05 15:13:04
Documents
7
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR THE YEAR ENDED SEPTEMBER 30, 2009 form10k.htm 10-K 320687
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER exhibit31-1.htm EX-31.1 6922
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER exhibit31-2.htm EX-31.2 6919
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER exhibit32-1.htm EX-32.1 2653
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER exhibit32-2.htm EX-32.2 2653
6 dmlogo.jpg GRAPHIC 16225
7 dmfoot.jpg GRAPHIC 13204
  Complete submission text file 0001062993-10-000014.txt   382141
Mailing Address 1594 STONE MILL PARK P.O. 55 BELLONA NY 14415
Business Address 1594 STONE MILL PARK P.O. 55 BELLONA NY 14415 416-262-9974
Pure Pharmaceuticals CORP (Filer) CIK: 0001364326 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-52885 | Film No.: 10506323
SIC: 2834 Pharmaceutical Preparations